Clinical Trial Update: Methods of T Cell Depletion Trial (MoTD) [Phase 2]

View source ↗

Summary

Phase 2 trial update for methods of T cell depletion in various hematologic malignancies is ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia
• Hodgkin Lymphoma
• Multiple Myeloma
• Myelodysplastic Syndromes
• Myelofibrosis
• Myelogenous Leukemia
• Myelomonocytic Leukemia
• Non-hodgkin Lymphoma

Snippet

Sponsor: University of Birmingham | Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 2 | Status: UNKNOWN